Immunomodulatory effects of anti-tumour necrosis factor α: relationships with Behcet disease clinical characteristics

被引：0
|
作者：
Messaoudene, D. [1 ]
机构：
[1] Univ Boumerdes, Boumerdes, Algeria
来源：
IMMUNOLOGY | 2014年 / 143卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
611
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [31] Paradoxical reactions of anti-tumour necrosis factor in inflammatory diseases
    Karray, M.
    Youssef, S.
    Alkhathiri, M.
    Fatima, A.
    Nour, A.
    Jaber, K.
    Dhaoui, R.
    Doss, N.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 101 - 102
  • [32] European guidelines for the use of anti-tumour necrosis factor agents in inflammatory bowel disease
    Kruis, W
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (01) : 12 - 13
  • [33] How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease
    Naviglio, Samuele
    Giuffrida, Paolo
    Stocco, Gabriele
    Lenti, Marco Vincenzo
    Ventura, Alessandro
    Corazza, Gino Roberto
    Di Sabatino, Antonio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (08) : 797 - 810
  • [34] Anti-tumour necrosis factor-α treatment for perianal Crohn's disease in Australia
    Burger, Daniel C.
    Lawrance, Ian C.
    Bampton, Peter A.
    Prosser, Ruth
    Croft, Anthony
    Gilshenan, Kristen
    Radford-Smith, Graham L.
    Florin, Timothy H.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (07) : 375 - 377
  • [35] Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept)
    Yazisiz, V.
    Avci, A. B.
    Erbasan, F.
    Yildirim, B.
    Terzioglu, E.
    COLORECTAL DISEASE, 2008, 10 (09) : 953 - 954
  • [36] Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients
    Mohabbat, A. B.
    Sandborn, W. J.
    Loftus, E. V., Jr.
    Wiesner, R. H.
    Bruining, D. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) : 569 - 574
  • [37] Granuloma annulare induced by anti-tumour necrosis factor therapy
    Voulgari, P. V.
    Markatseli, T. E.
    Exarchou, S. A.
    Zioga, A.
    Drosos, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (04) : 567 - 570
  • [38] Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy
    Schnarr, S
    Kuipers, JG
    Zeidler, H
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S126 - S129
  • [39] Immunogenicity of anti-tumour necrosis factor drugs in rheumatic diseases
    Spinelli, F. R.
    Valesini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 954 - 963
  • [40] European guidelines for the use of anti-tumour necrosis factor agents in inflammatory bowel disease
    Wolfgang Kruis
    International Journal of Colorectal Disease, 2001, 16 : 12 - 13
12345